Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal.
作者信息
Joob Beuy, Wiwanitkit Viroj
机构信息
Sanitation 1 Medical Academic Center, Bangkok, Thailand
Department of Community Medicine, Dr DY Patil University, Pune, India.
出版信息
Ann Rheum Dis. 2021 Feb;80(2):e24. doi: 10.1136/annrheumdis-2020-217695. Epub 2020 May 13.
Abstract
摘要
相似文献
1
Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal.
Ann Rheum Dis. 2021 Feb;80(2):e24. doi: 10.1136/annrheumdis-2020-217695. Epub 2020 May 13.
2
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.羟氯喹能保护风湿病患者免受新型冠状病毒肺炎（COVID-19）感染吗？对Heldwein和Calado所著的《羟氯喹能预防新型冠状病毒肺炎（COVID-19）传播吗？》以及Joob和Wiwanitkit所著的《系统性红斑狼疮、羟氯喹与非系统性红斑狼疮的新型冠状病毒肺炎（COVID-19）患者：一则评论》的回应
Ann Rheum Dis. 2020 Jun;79(6):e62. doi: 10.1136/annrheumdis-2020-217524. Epub 2020 Apr 23.
3
No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit.目前尚无证据表明羟氯喹对预防新冠病毒病具有保护作用：乔布和维瓦尼特基的评论
Ann Rheum Dis. 2021 Feb;80(2):e22. doi: 10.1136/annrheumdis-2020-217665. Epub 2020 May 13.
4
SLE patients are not immune to covid-19: importance of sending the right message across.系统性红斑狼疮患者并非对新冠病毒免疫：传递正确信息的重要性。
Ann Rheum Dis. 2021 Feb;80(2):e23. doi: 10.1136/annrheumdis-2020-217658. Epub 2020 Apr 23.
5
Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal .
Ann Rheum Dis. 2021 May;80(5):e72. doi: 10.1136/annrheumdis-2020-218146. Epub 2020 Jul 15.
6
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.评估系统性红斑狼疮患者接种 SARS-CoV-2 疫苗后的免疫反应和疾病状况。
Arthritis Rheumatol. 2022 Feb;74(2):284-294. doi: 10.1002/art.41937. Epub 2021 Dec 28.
7
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.COVID-19 患者伴系统性红斑狼疮，SARS-CoV-2 RNA 阳性复发后成功康复：病例报告及文献复习。
Clin Rheumatol. 2020 Sep;39(9):2803-2810. doi: 10.1007/s10067-020-05230-0. Epub 2020 Jul 28.
8
SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.系统性红斑狼疮、羟氯喹与非系统性红斑狼疮的新冠肺炎患者：一则评论
Ann Rheum Dis. 2020 Jun;79(6):e61. doi: 10.1136/annrheumdis-2020-217506. Epub 2020 Apr 15.
9
COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study.贝利尤单抗治疗的系统性红斑狼疮患者中的新型冠状病毒肺炎：一项回顾性临床研究。
Immunol Res. 2024 Jun;72(3):418-429. doi: 10.1007/s12026-023-09449-2. Epub 2023 Dec 22.
10
SARS-CoV-2 and Systemic Lupus Erythematosus.新型冠状病毒与系统性红斑狼疮。
Curr Rheumatol Rep. 2021 Jan 28;23(2):8. doi: 10.1007/s11926-020-00973-w.
Zotero 插件